Dato’ Seri Ivan Teh, the founder and CEO of Fusionex, has been named to the academic council of the International Medical University’s Digital Health Graduate Program (IMU). Source: Business Wire photo. Malaysia’s Kuala Lumpur—(BUSINESS WIRE)—Dato’ Seri Ivan Teh, the founder and group CEO of Fusionex, has been named to the Graduate Program in Digital Health Academic Committee at the International Medical University (IMU). Upon the appointment, Teh will lend his expertise and knowledgeable experience to the development and growth of the programme.
“I am very honored to have been selected as a faculty member for the Digital Health Graduate Program at IMU. The digital space for the healthcare industry is full of great challenges & potential as it needs to unlock critical insights through the effective use of technology to improve overall health and save countless lives at risk. IMU is an outstanding organization with a large group of enthusiasts. I look forward to working with IMU, and I am committed to it, contributing in any way or size to help grow the program,” said Teh. The Digital Health Bachelor of Arts degree program prepares students for healthcare technology careers, where the future of healthcare will be taught through new technologies. Through the use of big data analytics, artificial intelligence, and machine learning skills that students will gather through this program, these students can develop better healthcare solutions, such as digital hospital information systems, platforms, and clinical decision aids, to mention a few. In addition to this appointment, Fusionex has already collaborated with IMU on a program that diversified the use of Big Data Analytics and Artificial Intelligence (AI) in IMU’s medical and health science programs.
“Healthcare is improving so fast, especially after the Covid-19 pandemic, people are very aware of the importance of the profession. The future of healthcare is hampered by many question marks and uncertainties. We need to support the healthcare industry in any way we can because the challenges ahead are far greater than any one sector can bear alone. Traditional methods cannot cope with the speed and volume of resources faced by the industry. Using cutting-edge With the use of technologies like artificial intelligence (AI), machine learning, big data, and the Internet of Things, medical practitioners can not only provide patients with better care but also make successful treatment decisions based on trend analysis and predictive diagnosis. Ultimately, this leads to one thing that can save many lives,” Teh said.
Concerning Fusionex, Fusionex is a well-known, multiple-award-winning data technology company with experience in artificial intelligence, machine learning, big data, analytics, and IR 4.0. Its offerings focus on helping customers unlock value and gain insights from data. Featured in Forbes, Bloomberg, Gartner, IDC, Forrester, Edison, and Huffington Post, Fusionex is ASEAN’s most significant data analytics company and market leader, delivering innovative, and progressive data-driven content and client stable (Fortune 500, FTSE companies, large corporations and a wide range of small and medium enterprises (SMEs) spanning the United States, Europe and Asia Pacific Fusionex is also an MDEC GAIN subsidiary as well and MGS is the acquirer. Fusionex’s data technology platform was recognized and shortlisted in Gartner’s 2018 report on modern analytics and business intelligence. Furthermore, Fusionex is a critical player in the Big Data & Analytics MarketScape Report published by IDC. As the only business in ASEAN to be mentioned in both reports, Fusionex has enhanced its standing in the data technology sector in the area.